Vericel Corp Ord Stock Performance

VCEL Stock  USD 37.41  0.59  1.60%   
The entity has a beta of 1.18, which indicates a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Vericel Corp will likely underperform. Vericel Corp Ord right now has a risk of 2.97%. Please validate Vericel Corp skewness, and the relationship between the potential upside and rate of daily change , to decide if Vericel Corp will be following its existing price patterns.

Risk-Adjusted Performance

Weakest

 
Weak
 
Strong
Over the last 90 days Vericel Corp Ord has generated negative risk-adjusted returns adding no value to investors with long positions. Despite quite persistent technical and fundamental indicators, Vericel Corp is not utilizing all of its potentials. The latest stock price mess, may contribute to short-term losses for the institutional investors. ...more
Begin Period Cash Flow86.9 M
Total Cashflows From Investing Activities-79 M

Vericel Corp Relative Risk vs. Return Landscape

If you would invest  3,785  in Vericel Corp Ord on November 20, 2025 and sell it today you would lose (44.00) from holding Vericel Corp Ord or give up 1.16% of portfolio value over 90 days. Vericel Corp Ord is currently generating 0.0233% in daily expected returns and assumes 2.9651% risk (volatility on return distribution) over the 90 days horizon. In different words, 26% of stocks are less volatile than Vericel, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon.
  Expected Return   
       Risk  
Given the investment horizon of 90 days Vericel Corp is expected to generate 5.99 times less return on investment than the market. In addition to that, the company is 3.95 times more volatile than its market benchmark. It trades about 0.01 of its total potential returns per unit of risk. The Dow Jones Industrial is currently generating roughly 0.19 per unit of volatility.

Vericel Corp Target Price Odds to finish over Current Price

The tendency of Vericel Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
Current PriceHorizonTarget PriceOdds to move above the current price in 90 days
 37.41 90 days 37.41 
about 47.68
Based on a normal probability distribution, the odds of Vericel Corp to move above the current price in 90 days from now is about 47.68 (This Vericel Corp Ord probability density function shows the probability of Vericel Stock to fall within a particular range of prices over 90 days) .
Given the investment horizon of 90 days the stock has the beta coefficient of 1.18 . This entails as the benchmark fluctuates upward, the company is expected to outperform it on average. However, if the benchmark returns are projected to be negative, Vericel Corp will likely underperform. Additionally Vericel Corp Ord has a negative alpha, implying that the risk taken by holding this instrument is not justified. The company is significantly underperforming the Dow Jones Industrial.
   Vericel Corp Price Density   
       Price  

Predictive Modules for Vericel Corp

There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Vericel Corp Ord. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Vericel Corp's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Hype
Prediction
LowEstimatedHigh
34.4437.4140.38
Details
Intrinsic
Valuation
LowRealHigh
29.5732.5441.15
Details
Naive
Forecast
LowNextHigh
35.1338.0941.06
Details
Bollinger
Band Projection (param)
LowerMiddle BandUpper
15.7935.8355.86
Details

Vericel Corp Risk Indicators

For the most part, the last 10-20 years have been a very volatile time for the stock market. Vericel Corp is not an exception. The market had few large corrections towards the Vericel Corp's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Vericel Corp Ord, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Vericel Corp within the framework of very fundamental risk indicators.
α
Alpha over Dow Jones
-0.03
β
Beta against Dow Jones1.18
σ
Overall volatility
1.55
Ir
Information ratio -0.0079

Vericel Corp Alerts and Suggestions

In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Vericel Corp for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Vericel Corp Ord can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.
Over 99.0% of the company outstanding shares are owned by institutional investors

Vericel Corp Price Density Drivers

Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Vericel Stock often depends not only on the future outlook of the current and potential Vericel Corp's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Vericel Corp's indicators that are reflective of the short sentiment are summarized in the table below.
Common Stock Shares Outstanding51.7 M
Cash And Short Term Investments116.2 M

Vericel Corp Fundamentals Growth

Vericel Stock prices reflect investors' perceptions of the future prospects and financial health of Vericel Corp, and Vericel Corp fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Vericel Stock performance.

About Vericel Corp Performance

By examining Vericel Corp's fundamental ratios, stakeholders can obtain critical insights into Vericel Corp's financial health, operational efficiency, and overall profitability. These insights assist in making well-informed investment and management decisions. For example, a high Return on Assets and Return on Equity would indicate that Vericel Corp is effectively utilizing its assets and equity to generate significant profits, enhancing its appeal to investors. On the other hand, low ROA and ROE values could reveal issues in asset and equity management, highlighting the need for operational improvements.
Vericel Corporation, a commercial-stage biopharmaceutical company, engages in the research, development, manufacture, and distribution of cellular therapies for sports medicine and severe burn care markets in the United States. Vericel Corporation was incorporated in 1989 and is headquartered in Cambridge, Massachusetts. Vericel operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 281 people.

Things to note about Vericel Corp Ord performance evaluation

Checking the ongoing alerts about Vericel Corp for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Vericel Corp Ord help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
Over 99.0% of the company outstanding shares are owned by institutional investors
Evaluating Vericel Corp's performance can involve analyzing a variety of financial metrics and factors. Some of the key considerations to evaluate Vericel Corp's stock performance include:
  • Analyzing Vericel Corp's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
  • Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Vericel Corp's stock is overvalued or undervalued compared to its peers.
  • Examining Vericel Corp's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
  • Evaluating Vericel Corp's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Vericel Corp's management team can help you assess the Company's leadership.
  • Pay attention to analyst opinions and ratings of Vericel Corp's stock. These opinions can provide insight into Vericel Corp's potential for growth and whether the stock is currently undervalued or overvalued.
It's essential to remember that evaluating Vericel Corp's stock performance is not an exact science, and many factors can impact Vericel Corp's stock market price. Therefore, it's also important to diversify your portfolio and not rely solely on one company or stock for your investments.
When determining whether Vericel Corp Ord is a strong investment it is important to analyze Vericel Corp's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Vericel Corp's future performance. For an informed investment choice regarding Vericel Stock, refer to the following important reports:
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Vericel Corp Ord. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in discontinued.
You can also try the Price Transformation module to use Price Transformation models to analyze the depth of different equity instruments across global markets.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Vericel Corp. If investors know Vericel will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. Comprehensive Vericel Corp assessment requires weighing all these inputs, though not all factors influence outcomes equally.
Investors evaluate Vericel Corp Ord using market value (trading price) and book value (balance sheet equity), each telling a different story. Calculating Vericel Corp's intrinsic value - the estimated true worth - helps identify when the stock trades at a discount or premium to fair value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. External factors like market trends, sector rotation, and investor psychology can cause Vericel Corp's market price to deviate significantly from intrinsic value.
Please note, there is a significant difference between Vericel Corp's value and its price as these two are different measures arrived at by different means. Investors typically determine if Vericel Corp is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. Conversely, Vericel Corp's market price signifies the transaction level at which participants voluntarily complete trades.